Pyxus International, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OID
Pyxus International, Inc. announced the outcomes of its 2026 annual shareholder meeting, including the election of directors and ratification of auditors.
OID
Pyxus International announced its first quarter fiscal 2027 results, showing a decrease in sales but improved gross profit margin and a strengthened balance sheet, while maintaining full-year guidance.
OID
Pyxus International announced robust fourth quarter and fiscal year 2026 financial results, highlighted by a 35.2% year-over-year increase in Q4 net sales and record full-year Adjusted EBITDA.
OID
Pyxus International, Inc. announced strong third-quarter fiscal 2026 results, including $16.9 million in net income and adjusted EBITDA equal to last year's record, while reaffirming full-year guidance.
OID
Pyxus International, Inc. announced solid second quarter fiscal 2026 results, achieving gross margin expansion and increased operating income, leading to updated full-year sales and adjusted EBITDA guidance.
OID
Pyxus International, Inc. shareholders re-elected all director nominees and approved the independent auditors, executive compensation, and the 2020 Incentive Plan at their 2025 annual meeting.
OID
Pyxus International, Inc. reports first quarter fiscal 2026 results, including a net loss of $15.8 million, which align with internal expectations, and reiterates full-year guidance.
OID
Pyxus International, Inc. has announced the resignation of its Chief Accounting Officer, Philip C. Garofolo, effective June 27, 2025, and the appointment of Christopher G. Meredith as his successor.
OID
Pyxus International, Inc. announced exceptional financial results for its fiscal year ended March 31, 2025, showcasing substantial revenue growth, improved profitability, and a significant reduction in its leverage ratio to a 10-year low.
OID
Pyxus International's subsidiary, Pyxus Holdings, amends its ABL Credit Agreement, increasing the credit facility by $30 million and extending the maturity date to May 2030.
OID
Pyxus International amends its 2020 Incentive Plan, increasing the authorized share count to incentivize employees and board members.
OID
Flavia B. Landsberg, Executive Vice President and Chief Financial Officer of Pyxus International, Inc., has resigned effective February 28, 2025, and Dustin L. Styons has been appointed as Interim CFO.
OID
Pyxus International announces a robust third quarter for fiscal year 2025, driven by increased revenues and profitability, leading to an upward revision of its full-year guidance.
OID
Pyxus International reports strong first-half results for fiscal year 2025, leading to increased full-year revenue and adjusted EBITDA guidance.
OID
Pyxus International held its 2024 annual meeting, electing directors, ratifying auditors, and approving executive compensation and an incentive plan.
OID
Pyxus International announced a strong first quarter for fiscal year 2025, with sales increasing by 33.1% to $634.9 million, driven by price strength and volume growth.
OID
Pyxus International, Inc. has implemented a new Executive Severance Plan to provide increased certainty for executive officers and the company in the event of a severance.
OID
Pyxus International announced strong fiscal year 2024 results, including revenue growth, improved margins, and significant debt reduction.
OID
Pyxus International has extended the deadline for its stock listing condition for restricted stock units and approved new award agreements for executives and key employees.
OID
Pyxus International's Board of Directors has amended its 2020 Incentive Plan, increasing the number of authorized shares for issuance from 2.2 million to 3.22 million.
OID
Pyxus International is set to reduce its long-term debt by $142.9 million, significantly strengthening its capital structure.
OID
Pyxus International announced strong third-quarter and year-to-date fiscal 2024 results, driven by margin gains and increased average pricing, leading to an upward revision of full-year guidance.